Sculptra®... a sculpting agent that restores volume to correct the signs of facial fat loss.

About Sculptra®
Sculptra® is an enduring treatment approved by the FDA for restoration and/or correction of the signs of facial fat loss, or lipoatrophy, in people with human immunodeficiency virus. It is the first FDA-approved product of its kind for this condition.

Facial fat loss, or lipoatrophy, is the loss of fat beneath the skin, which can result in sunken cheeks, indentations, and hollow eyes. Sculptra® is a safe, synthetic, and biocompatible material that is injected below the surface of the skin in the area of fat loss. It provides a gradual and significant increase in skin thickness, improving the appearance of folds and sunken areas. No skin testing is required.

What It Does
Sculptra® is an injectable product that restores and corrects the signs of facial fat loss by replacing lost volume. Sculptra® provides an increase in skin thickness, helping to create a more natural facial appearance in those with facial lipoatrophy.

Lasting Results
The effects of Sculptra® are enduring. In a clinical study, effects lasted for up to 2 years after the first treatment session in most patients. The results from Sculptra® are not immediate; Sculptra® provides a gradual increase in skin thickness. Your healthcare provider will see you again in a few weeks to decide if additional injections are needed. Touch-up treatments may be needed to maintain the desired effects.

People with mild lipoatrophy will require fewer treatments than those with severe lipoatrophy.

How many treatments are required?
Your healthcare provider will decide the appropriate number of treatment sessions and the amount of Sculptra® you will need at each session. Patients with severe facial fat loss may require 3 to 6 treatment sessions.